Can-Fite BioPharma (CANF) Signs to Develop Commercial Biomarker Test for A3AR
Tweet Send to a Friend
Can-Fite BioPharma Ltd. (AMEX: CANF) has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE